Namita Jain Deepak Sharma Renu Agrawal Adeesh Jain
10.1159/000381806
Med Princ Pract
2015;24(3):291-3.
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/25896670/
Abnormalities, Drug-Induced / physiopathology Antineoplastic Agents / toxicity Imatinib Mesylate / toxicity
Abnormalities, Drug-Induced / physiopathology Antineoplastic Agents / toxicity Imatinib Mesylate / toxicity Case Reports Antineoplastic Agents / therapeutic use Female Humans Imatinib Mesylate / therapeutic use Infant, Low Birth Weight Infant, Newborn Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy Male Pregnancy Pregnancy Complications, Neoplastic / drug therapy Antineoplastic Agents Imatinib Mesylate
PMC5588294
25896670
A newborn with teratogenic effect of imatinib mesylate: a very rare case report
2015